Daniel J. DiStefano

1.4k total citations
22 papers, 645 citations indexed

About

Daniel J. DiStefano is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Daniel J. DiStefano has authored 22 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Daniel J. DiStefano's work include Viral gastroenteritis research and epidemiology (6 papers), HIV Research and Treatment (6 papers) and Respiratory viral infections research (5 papers). Daniel J. DiStefano is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), HIV Research and Treatment (6 papers) and Respiratory viral infections research (5 papers). Daniel J. DiStefano collaborates with scholars based in United States, India and Belgium. Daniel J. DiStefano's co-authors include H. F. Clark, Alan Shaw, Danilo R. Casimiro, Ming‐Tain Lai, Michael D. Miller, Amy S. Espeseth, Jessica A. Flynn, Daria J. Hazuda, Sinoeun Touch and Cheryl Callahan and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Daniel J. DiStefano

22 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. DiStefano United States 14 369 306 189 97 88 22 645
Tamara Bar-Magen Canada 13 508 1.4× 84 0.3× 387 2.0× 112 1.2× 84 1.0× 16 668
Carolyn A. Luscombe Australia 15 260 0.7× 434 1.4× 84 0.4× 42 0.4× 62 0.7× 24 628
Jean‐Pierre Allain United Kingdom 14 541 1.5× 456 1.5× 330 1.7× 23 0.2× 57 0.6× 16 1.1k
Marcy E. Armstrong United States 8 155 0.4× 318 1.0× 42 0.2× 41 0.4× 29 0.3× 8 468
William M. Hurni United States 13 184 0.5× 392 1.3× 219 1.2× 25 0.3× 26 0.3× 25 804
Mary Clare Walker United States 11 357 1.0× 229 0.7× 646 3.4× 69 0.7× 63 0.7× 25 911
Stephanie Wurr Germany 10 683 1.9× 279 0.9× 34 0.2× 67 0.7× 26 0.3× 16 904
Jessica A. Flynn United States 11 248 0.7× 372 1.2× 125 0.7× 21 0.2× 56 0.6× 18 668
Helga Ruebsamen‐Schaeff Germany 14 260 0.7× 859 2.8× 131 0.7× 23 0.2× 14 0.2× 24 1.1k
Larry E. Westerman United States 11 240 0.7× 83 0.3× 72 0.4× 105 1.1× 75 0.9× 19 396

Countries citing papers authored by Daniel J. DiStefano

Since Specialization
Citations

This map shows the geographic impact of Daniel J. DiStefano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. DiStefano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. DiStefano more than expected).

Fields of papers citing papers by Daniel J. DiStefano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. DiStefano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. DiStefano. The network helps show where Daniel J. DiStefano may publish in the future.

Co-authorship network of co-authors of Daniel J. DiStefano

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. DiStefano. A scholar is included among the top collaborators of Daniel J. DiStefano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. DiStefano. Daniel J. DiStefano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zohar, Tomer, Nickita Mehta, Jishnu Das, et al.. (2021). Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates. Cell Host & Microbe. 30(1). 41–52.e5. 48 indexed citations
2.
Wen, Zhiyun, Andrew J. Bett, Amy S. Espeseth, et al.. (2018). Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging. Journal of Virological Methods. 263. 88–95. 13 indexed citations
3.
Li, Hualin, Cheryl Callahan, Michael Citron, et al.. (2017). Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys. PLoS ONE. 12(11). e0187642–e0187642. 17 indexed citations
5.
Kesavardhana, Sannula, Michael Citron, Daniel J. DiStefano, et al.. (2016). Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies. Journal of Biological Chemistry. 292(1). 278–291. 8 indexed citations
6.
Cox, Kara S., Aimin Tang, Zhifeng Chen, et al.. (2015). Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. mAbs. 8(1). 129–140. 28 indexed citations
8.
Lai, Ming‐Tain, Meizhen Feng, Jean‐Pierre Falgueyret, et al.. (2013). In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrobial Agents and Chemotherapy. 58(3). 1652–1663. 104 indexed citations
9.
Awasthi, Sita, John W. Balliet, Jessica A. Flynn, et al.. (2013). Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs. Journal of Virology. 88(4). 2000–2010. 37 indexed citations
10.
Clark, H. F., et al.. (2011). An unusual outbreak of rotavirus genotype G2P[6] during the 2005–2006 epidemic season in Philadelphia. Diagnostic Microbiology and Infectious Disease. 70(2). 218–222. 12 indexed citations
13.
Jones, Kristen L., M. Katharine Holloway, Hua-Poo Su, et al.. (2010). Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4065–4068. 7 indexed citations
14.
Mast, T. Christopher, et al.. (2010). Burden of Childhood Rotavirus Disease on Health Systems in the United States. The Pediatric Infectious Disease Journal. 29(2). e19–e25. 39 indexed citations
15.
Rajapakse, Hemaka A., Abbas M. Walji, Keith P. Moore, et al.. (2010). Strategies towards Improving the Pharmacokinetic Profile of ε‐Substituted Lysinol‐Derived HIV Protease Inhibitors. ChemMedChem. 6(2). 253–257. 4 indexed citations
16.
Smith, Michael J., H. F. Clark, Louis M. Bell, et al.. (2008). The Clinical and Molecular Epidemiology of Community- and Healthcare-Acquired Rotavirus Gastroenteritis. The Pediatric Infectious Disease Journal. 27(1). 54–58. 17 indexed citations
18.
Zerboni, Leigh, Marvin Sommer, Hideki Ito, et al.. (2004). Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology. 332(1). 337–346. 46 indexed citations
19.
Palker, T J, Irina Kiseleva, Qin Su, et al.. (2004). Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. Virus Research. 105(2). 183–194. 12 indexed citations
20.
DiStefano, Daniel J., et al.. (1995). Titration of human-bovine rotavirus reassortants using a tetrazolium-based colorimetric end-point dilution assay. Journal of Virological Methods. 55(2). 199–208. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026